» Articles » PMID: 1532769

Osteoporosis and Klinefelter's Syndrome

Overview
Specialty Endocrinology
Date 1992 Jan 1
PMID 1532769
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We wanted to measure forearm mineral density and bone-related biochemical variables in patients with Klinefelter's syndrome.

Design: Measurements made in patients with Klinefelter's syndrome were compared to those obtained in age-matched normal male volunteers.

Patients: We studied 22 patients with Klinefelter's syndrome (12 of whom had received sex hormone therapy) and 22 control subjects.

Measurements: We measured forearm mineral density, forearm fat content, fat-corrected forearm mineral density, plasma calcium and ionized calcium, serum osteocalcin, testosterone and dehydroepiandrosterone sulphate, and urinary hydroxyproline/creatinine ratio.

Results: Forearm mineral density was lower in the Klinefelter's group than in the control subjects (P less than 0.05) and below the control range in 5 patients. The fat content of the forearm was greater in the Klinefelter's group (P less than 0.002). Serum osteocalcin and testosterone were lower, while ionized calcium and the urinary hydroxyproline/creatinine ratio were higher in the Klinefelter's group (P less than 0.002). Serum dehydroepiandrosterone sulphate and testosterone were significantly related in the Klinefelter's group (r = 0.64, P less than 0.001), but not in the controls (r = 0.22, NS). Forearm mineral density and fat-corrected forearm mineral density were significantly related to serum testosterone in the Klinefelter's group (r less than 0.63; P less than 0.01), but not in the control subjects (r less than 0.03, NS).

Conclusions: Decreased bone density occurs in about 25% of patients with Klinefelter's syndrome and probably reflects both decreased bone formation and increased bone resorption.

Citing Articles

Bone mineralization and immediate function of six dental implants in patients with Klinefelter syndrome.

Ciobanu G, De Angelis F, Slabari E, Pompa G Clin Case Rep. 2021; 9(10):e03142.

PMID: 34631058 PMC: 8489383. DOI: 10.1002/ccr3.3142.


Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy.

Chen J, Lin P, Tsai Y, Yang Y, Kang H Cells. 2019; 8(11).

PMID: 31731497 PMC: 6912771. DOI: 10.3390/cells8111318.


Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.

Ferlin A, Selice R, Di Mambro A, Ghezzi M, Di Nisio A, Caretta N Osteoporos Int. 2015; 26(8):2193-202.

PMID: 25963234 DOI: 10.1007/s00198-015-3136-8.


Type 1 diabetes and osteoporosis: A review of literature.

Dhaon P, Shah V Indian J Endocrinol Metab. 2014; 18(2):159-65.

PMID: 24741510 PMC: 3987264. DOI: 10.4103/2230-8210.129105.


The role of hypogonadism in Klinefelter syndrome.

Host C, Skakkebaek A, Groth K, Bojesen A Asian J Androl. 2014; 16(2):185-91.

PMID: 24407186 PMC: 3955327. DOI: 10.4103/1008-682X.122201.